Article info

Download PDFPDF

Clarification regarding the statement of the association between the recombinant zoster vaccine (RZV) and gout flares
Free

Authors

  1. Correspondence to Dr. Arnaud M Didierlaurent, GSK, Wavre 1300, Belgium; arnaud.x.didierlaurent{at}gsk.com
View Full Text

Citation

Didierlaurent AM, Desssart C, Cunningham AL
Clarification regarding the statement of the association between the recombinant zoster vaccine (RZV) and gout flares

Publication history

  • Received November 13, 2019
  • Accepted November 17, 2019
  • First published December 2, 2019.
Online issue publication 
February 28, 2022

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.